Stefan Hauser

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 278 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617

Hojjat Ahmadzadehfar, Simone Wegen, Anna Yordanova et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 173 citations

Medicine, Oncology, Pharmacology +17

Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with ¹⁷⁷Lu-PSMA-617

Justin Ferdinandus, Elisabeth Eppard, Florian Gaertner et al. · Journal of Nuclear Medicine · 2016 · 122 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

A 25-hydroxylation pathway of cholic acid biosynthesis in man and rat.

Sarah Shefer, F. W. Cheng, B. Dayal et al. · Journal of Clinical Investigation · 1976 · 117 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Isolation of Novel Multipotent Neural Crest-Derived Stem Cells from Adult Human Inferior Turbinate

Stefan Hauser, Darius Widera, Firas Qunneis et al. · Stem Cells and Development · 2011 · 116 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +10